Design Therapeutics, Inc. Common Stock (NASDAQ: DSGN) last traded at $14.99, down 3.66% on the session. The quote above updates while this page is open; the figures below are drawn from Design Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Design Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DSGN. Its market capitalisation is $938.10 million.
Valuation measures for Design Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $938.10M |
|---|---|
| Enterprise value | $938.46M |
| Price / book | 4.65 |
| Beta | 1.20 |
Trailing-twelve-month figures tagged in Design Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$70.80M |
| EPS (TTM) | -$1.18 |
| Return on equity | -35.07% |
| Cash | $12.91M |
Range and volume for DSGN over the past 52 weeks.
| 52-week high | $17.25 |
|---|---|
| 52-week low | $4.92 |
| Volume | 551.8K |
| Average volume | 743.5K |
| Previous close | $15.56 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.